You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Latvia

May 2012

Price: US$2,400

About this Report

EXECUTIVE SUMMARY

Recovery brings optimism

Consumer health finally showed signs of recovery during the review period with overall growth in 2011. The recovery, which started in the second half 2010, increased growth to pre-economic crisis levels. However, increasing demand also led to significant price growth. Despite good performance in 2011, 2008 levels were not yet achieved in volume and value terms. Faster growth was achieved by more expensive products, while in previous years these were the most vulnerable.

Improved economic situation benefits value sales

Performance of 2011 was defined by economic factors such as decreasing unemployment and growing consumer spending, which allowed Latvian consumers to be more critical about their choices and product quality. In addition, sales increased of products that are consumed as extras to the main products. Inflation levels also increased the average unit price as producers started to seek a return to profit after economic stagnation and artificial maintenance of volume sales from high number of discounts in 2009-2010.

More intense competition, but with different effects on consumer health

Competition continued to intensify in 2011, but varied significantly within consumer health. In most cases major players were able to maintain or slightly increase their share by sustaining average growth in line with common trend. In more fragmented categories, niche players were able to benefit from improved economic situation to achieve faster growth rate. Where sales are shared between several large players, smaller players lost market share. Intensification of competition was also seen in the development of private label in Latvia, showing that price or value for money started to matter for major consumers. This also showed that the number of different players with similar products could be high in some product areas.

Regulation limits changes in distribution

There were no significant changes in distribution in 2011. The major barrier for any changes is the regulation that allows medicines sales only through chemists/pharmacies. Regulation in 2011 requires the provision of mandatory consultation of a pharmacist which is only available through this channel. This regulation also limits private label, making products available only through chemists/pharmacies. However, this applies only to OTC products, while vitamins and dietary supplements and sports nutrition benefit from free market environment. Herbal/traditional products also have some exemptions within OTC, making sales of these products available via internet retailing.

Positive growth expected with few threats to growth

Consumer health will continue to grow over the forecast period with fewer threats to growth. Although economic performance will have an impact over the forecast period, only moderate effects are expected in case of another economic contraction. First half of forecast period is expected to witness faster growth rate compared to the second half, as recovery trend will be more intense in the short term. Niche players should benefit more from underdeveloped categories over forecast period. Faster developments in private label and natural and herbal products are expected compared to the average consumer health performance throughout the forecast period.


Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Latvia with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Latvia, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Latvia for free:

The Consumer Health in Latvia market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Latvia?
  • What are the major brands in Latvia?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Table of Contents

Consumer Health in Latvia - Industry Overview

EXECUTIVE SUMMARY

Recovery brings optimism

Improved economic situation benefits value sales

More intense competition, but with different effects on consumer health

Regulation limits changes in distribution

Positive growth expected with few threats to growth

KEY TRENDS AND DEVELOPMENTS

Economic factors as major driving force

International brands lead the sales

Herbal/traditional products grow faster

Less regulation benefits vitamins and dietary supplements

Private label has potential for growth

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  • Table 2 Life Expectancy at Birth 2006-2011

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2006-2011
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2006-2011
  • Table 5 Consumer Health Company Shares 2007-2011
  • Table 6 Consumer Health Brand Shares 2008-2011
  • Table 7 Penetration of Private Label by Category 2006-2011
  • Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  • Table 9 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 10 Forecast Sales of Consumer Health by Category: Value 2011-2016
  • Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

  • Summary 1 OTC Healthcare Switches 2009-2011

DEFINITIONS

SOURCES

  • Summary 2 Research Sources

Consumer Health in Latvia - Company Profiles

Grindeks AS in Consumer Health (Latvia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 5 Grindeks AS: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 6 Grindeks AS: Competitive Position 2011

Olainfarm AS in Consumer Health (Latvia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 9 Olainfarm AS: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 10 Olainfarm AS : Competitive Position 2011

Silvanols Ltd in Consumer Health (Latvia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 13 Silvanols Ltd: Competitive Position 2011

Adult Mouth Care in Latvia - Category Analysis

HEADLINES

TRENDS

  • Adult mouth care is small and products are used on advice of a dentist. It is difficult for medicated mouth care products to compete with cosmetics/everyday use mouth care products, as they are available mainly through chemists/pharmacies and parapharmacies/drugstores. As a result, no significant changes in trends were observed in 2011.

SWITCHES

COMPETITIVE LANDSCAPE

  • Arcam GmbH continued to lead adult mouth care in 2011. Company’s sales share in 2011 was 37% due to performance of its Lacalut brand. This brand is well-established and highly-recognised, and its performance is due to its promotion by dentists.

PROSPECTS

  • No significant changes are expected in the forecast period and dentists will continue to play an important role in adult mouth care products. It is stable as it is driven by the number of dental health problems. Adult mouth care is strongly reliant on dentists, who provide advice on medicated mouth care, as consumer awareness remains low. In addition, in Latvia people are less disposed towards dental-related mouth care compared to consumers in Western countries. However, there is potential that in the future medicated mouth care might have higher growth rates if higher consumer attention will result in stronger marketing activities.

CATEGORY DATA

  • Table 12 Sales of Adult Mouth Care: Value 2006-2011
  • Table 13 Sales of Adult Mouth Care: % Value Growth 2006-2011
  • Table 14 Adult Mouth Care Company Shares 2007-2011
  • Table 15 Adult Mouth Care Brand Shares 2008-2011
  • Table 16 Forecast Sales of Adult Mouth Care: Value 2011-2016
  • Table 17 Forecast Sales of Adult Mouth Care: % Value Growth 2011-2016

Analgesics in Latvia - Category Analysis

HEADLINES

TRENDS

  • In 2011, the preference for multi-purpose products significantly affected consumer decisions in analgesics in Latvia. In addition, changing attitudes towards cheaper products, especially the largest category of acetaminophen, and continuation of improving economic situation after significant economic downturn in 2008-2009, allowed more expensive categories to benefit in 2011. This contributed to the better performance of combination and ibuprofen products.

SWITCHES

COMPETITIVE LANDSCAPE

  • Bayer AG maintained its leading position in 2011 with 10% value share. The major success of this company derives from the performance of Aspirin and Saridon products. Ibumetin by Nycomed Group was the leading brand with 8% value share in 2011. Ibumetin 400 is in ibuprofen category, which is one of the most dynamic. Product's success was also due to high awareness of the brand, supported by effective promotion campaigns over review period. Although promotional activities for this product decreased in 2010-2011, it continued to be representative of ibuprofen products.

PROSPECTS

  • Over the forecast period analgesics is expected to have 1% CAGR growth. The universality of analgesics and its ability to reduce pain in line with other treatment will support growth. However, decreasing population and already wide application of these products will limit higher growth.

CATEGORY DATA

  • Table 18 Sales of Analgesics by Category: Value 2006-2011
  • Table 19 Sales of Analgesics by Category: % Value Growth 2006-2011
  • Table 20 Analgesics Company Shares 2007-2011
  • Table 21 Analgesics Brand Shares 2008-2011
  • Table 22 Forecast Sales of Analgesics by Category: Value 2011-2016
  • Table 23 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016

Calming and Sleeping in Latvia - Category Analysis

HEADLINES

TRENDS

  • In Latvia, there was faster growth for standard calming and sleeping products in 2011. The shift towards more expensive and higher quality products was the major contributor to growth in 2011.The trend of younger consumers using calming and sleeping products was also observed in 2011. In Latvia this trend intensified during the economic crisis in 2009-2010. Considering that younger generation was exposed to the negative economic factors in addition to slowly recovery, significant number of younger people continued facing financial problems and high unemployment rate. Prolonged unemployment and other financial issues cause more stress among younger population as higher level of mortgage loans and other credits were prevalent in this consumer group. Nevertheless, middle aged and elderly population remained major consumer segments in Latvia for calming and sleeping due to health conditions related to ageing.

SWITCHES

COMPETITIVE LANDSCAPE

  • Lek Pharmaceuticals was the leading company in calming and sleeping due to performance of its Persen brand in 2011. Company became the leader after the Corvalol brand was changed to Rx status and Validolum started to be positioned as dietary supplement in 2009.

PROSPECTS

  • Continuing trend of expansion of the consumer base is expected over forecast period in Latvia. Higher growth is expected among products that appeal to the younger population as opposed to the elderly, which will remain major consumers. It is expected that younger generation will return to consumption of calming and sleeping again and would rather buy brands they already know. The consumption of products that are popular among elderly population will decline with time due to age boundaries. In addition, younger population prefer to buy higher quality products, which are more expensive compared to what elderly consumers can afford, but improving economic situation should provide wider consumer base over forecast period. This is also relevant to mild natural products, such as teas, which started to gain wider acceptance and popularity.

CATEGORY DATA

  • Table 24 Sales of Calming and Sleeping: Value 2006-2011
  • Table 25 Sales of Calming and Sleeping: % Value Growth 2006-2011
  • Table 26 Calming and Sleeping Company Shares 2007-2011
  • Table 27 Calming and Sleeping Brand Shares 2008-2011
  • Table 28 Forecast Sales of Calming and Sleeping: Value 2011-2016
  • Table 29 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016

Cough, Cold and Allergy (Hay Fever) Remedies in Latvia - Category Analysis

HEADLINES

TRENDS

  • Cough, cold and allergy (hay fever) remedies had value growth in 2011. However, the number of influenza cases did not change significantly compared to 2010. Fluctuating temperature in summer resulted in higher sales performance of nasal sprays and inhalant decongestants. Allergy-related products also had higher growth rates, but this was due to the improved economic situation compared to 2009-2010, rather than growing allergy cases.

SWITCHES

COMPETITIVE LANDSCAPE

  • In 2011 Novartis AG continued to lead with 12% value share which increased by three percentage points compared to 2010. This was due to the success of its Theraflu, Vibrocil and Tavegyl brands. Theraflu has the largest share overall in cough, cold and allergy (hay fever) remedies, while Tavegyl has the highest share of antihistamines/allergy remedies. The success of Novartis AG is defined by its long presence on the market and customer recognition. This company also has the strongest advertising support.

PROSPECTS

  • In cough, cold and allergy (hay fever) remedies, a higher preference for combination products is expected throughout the forecast period resulting in it having the highest CAGR of 3% to reach LVL6 million. On the other hand, increasing consciousness regarding possible long term health impacts of standard OTC remedies will result in further growing share of herbal/traditional cough, cold and allergy (hay fever) remedies. Products containing dextromethorphan, pseudophedrine and acetaminophen are likely to be switched to Rx medication during first half of forecast period.

CATEGORY DATA

  • Table 30 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 32 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares 2007-2011
  • Table 33 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares 2008-2011
  • Table 34 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
  • Table 35 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016

Digestive Remedies in Latvia - Category Analysis

HEADLINES

TRENDS

  • In 2011 digestive remedies had substantial 9% growth to reach LVL5 million. The major driving forces were an increase in average unit price driven by inflation, and willingness of customers to purchase more expensive products compared to previous year. There were no special outbreaks of disease that would influence digestive remedies in Latvia in 2011.

SWITCHES

COMPETITIVE LANDSCAPE

  • Berlin-Chemie/Menarini Baltic SIA maintains its leading position as well as its 19% value share in digestive remedies in 2011. This share was achieved by good performance of such brands as Mezym Forte, Espumisan and Raniberl. No-Spa, produced by Sanofi-Aventis, on the other hand is the leading brand with 11% value share of digestive remedies in 2011. These brands benefit from their long presence and customer loyalty to big and well-known brands in Latvia.

PROSPECTS

  • Growth over the forecast period will depend on economic performance in Latvia. The dynamics of the economy will influence the average price and affect performance either of more expensive remedies in case of economic growth or towards cheaper products in case of stagnation. Another aspect that might impact performance and growth is possibility of switch of some Rx H2 blockers and proton pump inhibitors to OTC status.

CATEGORY DATA

  • Table 36 Sales of Digestive Remedies by Category: Value 2006-2011
  • Table 37 Sales of Digestive Remedies by Category: % Value Growth 2006-2011
  • Table 38 Digestive Remedies Company Shares 2007-2011
  • Table 39 Digestive Remedies Brand Shares 2008-2011
  • Table 40 Forecast Sales of Digestive Remedies by Category: Value 2011-2016
  • Table 41 Forecast Sales of Digestive Remedies by Category: % Value Growth 2011-2016

Ear Care in Latvia - Category Analysis

HEADLINES

TRENDS

  • In Latvia OTC ear care was small in 2011 as consumers usually visit the doctor when they have ear problems. This affected the sales of ear care products to treat infection or inflammation, as doctor might advise as Rx rather than OTC products. Products that clean the ear or soften ear wax were not considered by majority of consumers as a preventive measure in Latvia. Latvian consumers also tended to visit doctor in case of ear wax blocking the ear. In 2011 anti-inflammatory and pain reducing ear drops continued to lead sales.

SWITCHES

COMPETITIVE LANDSCAPE

  • ICN Polfa Rzeszow SA maintained its leadership in ear care with 14% market share in 2011. Company’s share solely relies on the performance of its Otinum brand. Its performance was partly driven by the product's positioning in anti-inflammatory and pain reducing ear care products.

PROSPECTS

  • Ear care is expected to remain limited in demand due to occasional consumer need for these products, especially in anti-inflammatory and pain relief ear care products. Products to clean the ear, products that soften ear wax and those that relieve swimmer’s ear will contribute to moderate growth, but this is not expected to be significant.

CATEGORY DATA

  • Table 42 Sales of Ear Care: Value 2006-2011
  • Table 43 Sales of Ear Care: % Value Growth 2006-2011
  • Table 44 Ear Care Company Shares 2007-2011
  • Table 45 Ear Care Brand Shares 2008-2011
  • Table 46 Forecast Sales of Ear Care: Value 2011-2016
  • Table 47 Forecast Sales of Ear Care: % Value Growth 2011-2016

Emergency Contraception in Latvia - Category Analysis

HEADLINES

TRENDS

  • Emergency contraception witnessed sales growth in 2011. The government was not successful in improving the birth rate, which could have affected development of emergency contraception in 2011. The birth rate remained stable and total population was decreasing in Latvia, which explained growth of emergency contraception.

SWITCHES

COMPETITIVE LANDSCAPE

  • Emergency contraception is solely represented by Richter Gedeon Nyrt with 100% value share. There are two brands offered by this company in Latvia. Postinor-2 is in Latvia since products were introduced and consists of two units per package which are consumed per contraception course. Escapelle consists of one unit but contains double the same active ingredient.

PROSPECTS

  • The continuation of existing trend is expected over forecast period. The government is not expected to be able to affect birth rate significantly over forecast period, making different contraception tools attractive for consumers in Latvia, among which emergency contraception could be an option.

CATEGORY DATA

  • Table 48 Sales of Emergency Contraception: Value 2006-2011
  • Table 49 Sales of Emergency Contraception: % Value Growth 2006-2011
  • Table 50 Emergency Contraception Company Shares 2007-2011
  • Table 51 Emergency Contraception Brand Shares 2008-2011
  • Table 52 Forecast Sales of Emergency Contraception: Value 2011-2016
  • Table 53 Forecast Sales of Emergency Contraception: % Value Growth 2011-2016

Eye Care in Latvia - Category Analysis

HEADLINES

TRENDS

  • Eye care sales were driven by performance of standard eye care products in 2011. The most common symptoms that these products treated were dry eye and red eye. The considerable share of sales was due to a stable base of consumers with permanent eye-related problems. Further growth was supported by products for tired or red eyes, which were used by people using optical lenses and those experiencing eye overload at work.

SWITCHES

COMPETITIVE LANDSCAPE

  • In Latvia Santen Oy maintains its leading position in eye care with 18% value share in 2011. Company’s performance is defined by success of such brands as Oftagel, Artelac and Lecrolyn. Visine by Pfizer Consumer Healthcare Ltd is the leading brand with 16% value share. The success of Visine was due to strong advertising support throughout review period.

PROSPECTS

  • Over forecast period further development of existing brands is expected. The potential for new entrants is in allergy eye care, where sales were insignificant in 2011. Consumers in Latvia are also expected to start searching for alternatives to antihistamines/allergy remedies (systemic) products.

CATEGORY DATA

  • Table 54 Sales of Eye Care by Category: Value 2006-2011
  • Table 55 Sales of Eye Care by Category: % Value Growth 2006-2011
  • Table 56 Standard Eye Care by Format: % Value Breakdown 2007-2011
  • Table 57 Standard Eye Care by Positioning 2007-2011
  • Table 58 Eye Care Company Shares 2007-2011
  • Table 59 Eye Care Brand Shares 2008-2011
  • Table 60 Forecast Sales of Eye Care by Category: Value 2011-2016
  • Table 61 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016

Herbal/Traditional Products in Latvia - Category Analysis

HEADLINES

TRENDS

  • Herbal/traditional products had faster growth than standard products in Latvia in 2011. Herbal/traditional products were present in almost all of consumer health and were more active in terms of new launches and developments compared to standard products.

COMPETITIVE LANDSCAPE

  • Rigas Farmaceitiska Fabrika A/S continued to lead herbal/tradition products sales in Latvia with 15% value share in 2011. Company has long experience in herbal/traditional remedies and a number of well-established, successful brands in Latvia. Its product portfolio included products such as Sausa Mikstura Pret Klepu, Baldriana Tinktura and Fenhela Teja. Sausa Mikstura Pret Klepu is also the leading brand with 7% of sales in 2011.

PROSPECTS

  • Over forecast period herbal/traditional products is expected to continue to grow as consumer preference for this type of products is expected to grow based increasing awareness of the environment. In addition, general perception of herbal/traditional products as products with fewer side effects is expected to remain in Latvia over forecast period.

CATEGORY DATA

  • Table 62 Sales of Herbal/Traditional Products: Value 2006-2011
  • Table 63 Sales of Herbal/Traditional Products: % Value Growth 2006-2011
  • Table 64 Herbal/Traditional Products Company Shares 2007-2011
  • Table 65 Herbal/Traditional Products Brand Shares 2008-2011
  • Table 66 Forecast Sales of Herbal/Traditional Products: Value 2011-2016
  • Table 67 Forecast Sales of Herbal/Traditional Products: % Value Growth 2011-2016

Medicated Skin Care in Latvia - Category Analysis

HEADLINES

TRENDS

  • Medicated skin care had overall growth in 2011 based on improving economic situation in Latvia. Growth was achieved as consumers became more willing to spend on skin disease treatment, especially those who were suffering from mild forms of skin problems. In addition, lower number of discount promotions compared to 2010 was another factor that affected growth.

SWITCHES

COMPETITIVE LANDSCAPE

  • Novartis AG continued to lead medicated skin care in Latvia with 19% value share in 2011. Company’s Lamisil brand was a major contributor to this performance with 14% value share of total medicated skin care. Lamisil brand has a long enough presence in Latvia and established good brand perception through proper marketing activities while being developed in Latvia. This product has wide presence in all pharmacy networks and high brand awareness associated with antifungals.

PROSPECTS

  • The economic environment in Latvia will be the major factor affecting growth over forecast period. Price fluctuations are another factor directly related with economic environment. Developments in paediatric medicated skin care, topical allergy remedies and hair loss treatment are expected in the second half of the forecast period.

CATEGORY DATA

  • Table 68 Sales of Medicated Skin Care by Category: Value 2006-2011
  • Table 69 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  • Table 70 Medicated Skin Care Company Shares by Value 2007-2011
  • Table 71 Medicated Skin Care Brand Shares 2008-2011
  • Table 72 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  • Table 73 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016

NRT Smoking Cessation Aids in Latvia - Category Analysis

HEADLINES

TRENDS

  • In 2011, tobacco products continued to increase in price, which were already high. This contributed to a growth rate of NRT smoking cessation aids, as more people wanted to stop smoking. The trend of decreasing smoking population in Latvia could be observed since 2000. In Latvia NRT smoking cessation aids is small and mainly represented by NRT patches and NRT gum.

SWITCHES

COMPETITIVE LANDSCAPE

  • Pharmacia & Upjohn and Novartis AG are the only significant players with 74% and 12% value share respectively in 2011. Pharmacia & Upjohn benefits due to well-established Nicorette brand represented by two products Nicorette 10mg plasters and Nicorette Freshmint. The companies were the first two to enter the market in Latvia and benefit from lack of competition.

PROSPECTS

  • Over forecast period NRT smoking cessation aids is expected to grow as the number of people wanting to stop smoking is expected to grow due to concerns about increased prices of tobacco products and development of health and wellness trend over the forecast period. Smoking prevalence in Latvia decreased in 2011 compared to previous year and was 43% for male and 15% for female population. On average over the forecast period, smoking is expected to decrease to 41% for male and 13% for female population by 2016. The leading companies in 2011 are expected to continue to lead, however if a new, strong entrant were to appear, strong marketing support would be essential to acquire significant market share.

CATEGORY INDICATORS

  • Table 74 Number of Smokers by Gender 2006-2011

CATEGORY DATA

  • Table 75 Sales of NRT Smoking Cessation Aids by Category: Value 2006-2011
  • Table 76 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2006-2011
  • Table 77 NRT Gum Flavours: % Value Breakdown 2006-2011
  • Table 78 NRT Smoking Cessation Aids Company Shares 2007-2011
  • Table 79 NRT Smoking Cessation Aids Brand Shares 2008-2011
  • Table 80 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2011-2016
  • Table 81 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2011-2016

Sports Nutrition in Latvia - Category Analysis

HEADLINES

TRENDS

  • Sports nutrition was a small category in Latvia in 2011 and relied mostly on athletes as its core consumers, while general consumers contributed to the faster growth rate. It only started to appeal to mass consumers towards the end of the review period, and was strongly reliant on number of people taking up sport. Widest acceptance of these products was among people who attend gyms and fitness centres, while other sport types were reluctant to use products in this category in Latvia.

COMPETITIVE LANDSCAPE

  • Weider Global Nutrition LLC continued to lead sports nutrition with 22% value share in 2011. Company has well-established, widely known brands such as CFM Whey Protein, Premium Whey Pro and Weider Mega Mass which are protein products. Company has long presence in Latvia and was able to maintain strong relationship with distributors.

PROSPECTS

  • Sports nutrition is expected to increase its popularity among mass consumers over forecast period. This will allow it to maintain further growth throughout the forecast period. There are two major factors expected to lead this trend. Firstly, growing awareness regarding sports nutrition driven by health and wellness trend. Secondly, more common positioning of products for active and sporting lifestyle rather than maintaining focus towards athletes only.

CATEGORY DATA

  • Table 82 Sales of Sports Nutrition: Value 2006-2011
  • Table 83 Sales of Sports Nutrition: % Value Growth 2006-2011
  • Table 84 Sports Nutrition Company Shares 2007-2011
  • Table 85 Sports Nutrition Brand Shares 2008-2011
  • Table 86 Forecast Sales of Sports Nutrition: Value 2011-2016
  • Table 87 Forecast Sales of Sports Nutrition: % Value Growth 2011-2016

Vitamins and Dietary Supplements in Latvia - Category Analysis

HEADLINES

TRENDS

  • The sales of vitamins and dietary supplements grew through major grocery retailers and direct selling in 2011. Wide availability and improved consumer confidence brought consumers back, who stopped buying vitamins and dietary supplements products during bad economic climate in Latvia in 2009-2011. While number of internet-based retailers is increasing, and a number of these appeared in 2011, this channel remained limited and underdeveloped. Purchase of vitamins and products for general health support is common through general grocery retailers and chemists/pharmacies, while dietary supplements consumed for specific health-related issues were usually bought through direct selling.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • In 2011 Grindeks AS led with 6% value share. However, vitamins and dietary supplements is very competitive and companies such as Whitehall-Cyanamid, Contract Pharmacal Corp A/S, Axellus A/S, Dansk Droge A/S and Roche Holding AG had 5% each. Grindeks AS only slightly outperformed its major rivals, as it benefited from a well-established name in herbal/traditional products and its products were perceived to be of good quality at a competitive price in Latvia.

PROSPECTS

  • Dietary supplements is expected to witness slightly faster growth over the forecast period. This expectation is based upon the growing education of Latvian consumers about daily diets and possible role of dietary supplements in human metabolism. However, vitamins is expected to continue to have the higher sales value by the end of forecast period. Based on the fact that vitamins is a commoditised category, strong development in private label is possible. At the first stage, most private label vitamins and dietary supplements products are expected to appear via pharmacy networks, but in the longer term, private label development in major retail networks should be expected.

CATEGORY DATA

  • Table 88 Summary1 Dietary Supplements: Brand Ranking by Positioning 2011
  • Table 89 Sales of Vitamins and Dietary Supplements by Category: Value 2006-2011
  • Table 90 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2006-2011
  • Table 91 Dietary Supplements by Positioning 2007-2011
  • Table 92 Vitamins and Dietary Supplements Company Shares 2007-2011
  • Table 93 Vitamins and Dietary Supplements Brand Shares 2008-2011
  • Table 94 Vitamins Brand Shares 2008-2011
  • Table 95 Dietary Supplements Brand Shares 2008-2011
  • Table 96 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2011-2016
  • Table 97 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2011-2016

Weight Management in Latvia - Category Analysis

HEADLINES

TRENDS

  • In 2011, women were the major consumer segment in weight management products followed by athletes and people with medical weight disorders. Growth was driven by improved economic climate which allowed consumers to spend more on their health and performance.

COMPETITIVE LANDSCAPE

  • Bional International BV had the largest value share at 23% in 2011. Company’s success is defined by well-established brand in the largest weight loss supplements. The second largest company was Certmedica International GmbH with 8% sales share; it has a long presence in Latvia.

PROSPECTS

  • Weight management is expected to sustain its strong focus on the female population. The growth rates over forecast period are expected to be the same as for review period. Slightly faster growth is expected in short term due to recovery after economic downturn in 2009-2010.

CATEGORY DATA

  • Table 98 Sales of Weight Management by Category: Value 2006-2011
  • Table 99 Sales of Weight Management by Category: % Value Growth 2006-2011
  • Table 100 Weight Management Company Shares 2007-2011
  • Table 101 Weight Management Brand Shares 2008-2011
  • Table 102 Forecast Sales of Weight Management by Category: Value 2011-2016
  • Table 103 Forecast Sales of Weight Management by Category: % Value Growth 2011-2016

Wound Care in Latvia - Category Analysis

HEADLINES

TRENDS

  • Wound care increased its value share through non-health retailers in 2011. The share of more expensive brands increased in 2011 as consumers were willing to spend more on higher quality products. Producers postponed introduction of new technologies or delivery formats, as a result such products as spray-on plasters were not present in Latvia. The major factor behind this was that producers wanted to develop more positive attitudes towards more expensive and higher quality products, because the high cost for new technologies would not be covered by consumer spending.

COMPETITIVE LANDSCAPE

  • SCA Molycke was the leader with 31% value share in 2011. The performance of the company is defined by two successful brands Mepore with 26% value share and Mefix with 5% in 2011. Mepore is more expensive with surgical wound specification, while Mefix offers more universal product range. Both brands perceived as high quality by consumers, as a result of close cooperation with chemists/pharmacies.

PROSPECTS

  • The trend towards more expensive wound care products will develop during first half of forecast period. During second half, development within private label will intensify, which will have a moderating effect on average unit price and size growth. However, new development and application of new technologies within the product group should contribute to growth and possibility of unit price decrease.

CATEGORY DATA

  • Table 104 Sales of Wound Care by Category: Value 2006-2011
  • Table 105 Sales of Wound Care by Category: % Value Growth 2006-2011
  • Table 106 Wound Care Company Shares 2007-2011
  • Table 107 Wound Care Brand Shares 2008-2011
  • Table 108 Forecast Sales of Wound Care by Category: Value 2011-2016
  • Table 109 Forecast Sales of Wound Care by Category: % Value Growth 2011-2016

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Paediatric Cough, Cold and Allergy Remedies
          • Paediatric Allergy Remedies
          • Paediatric Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Paediatric Digestive Remedies
          • Paediatric Diarrhoeal Remedies
          • Paediatric Indigestion and Heartburn Remedies
          • Paediatric Laxatives
          • Paediatric Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Paediatric Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
      • Protein Products
        • Bars
        • Powder
        • RTD
        • Other Protein
      • Non-Protein Products
    • Vitamins and Dietary Supplements
      • Paediatric Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
          • Non-Herbal Dietary Supplements
            • Calcium Supplements
            • Co-Enzyme Q10
            • Combination Non-Herbal Dietary Supplements
            • Eye Health Supplements
            • Fish Oils
              • Cod Liver Oil
              • Other Fish Oils
            • Glucosamine
            • Mineral Supplements
            • Omega-3-6-9 (Fish and Non-Fish)
            • Probiotic Supplements
            • Protein Powder
            • Royal Jelly
            • Sam-E
            • Other Non-Herbal Dietary Supplements
          • Tonics and Bottled Nutritive Drinks
          • Vitamins
            • Multivitamins
            • Single Vitamins
              • Vitamin A
              • Vitamin B
              • Vitamin C
              • Vitamin D
              • Vitamin E
              • Other Single Vitamins
        • Weight Management
          • Meal Replacement Slimming
          • OTC Obesity
          • Slimming Teas
          • Weight Loss Supplements
          • Other Slimming Products
        • Herbal/Traditional Products
          • Herbal/Traditional Analgesics
          • Herbal/Traditional Calming and Sleeping Products
          • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
          • Herbal/Traditional Digestive Remedies
          • Herbal/Traditional Medicated Skin Care
          • Herbal/Traditional Medicinal Teas
          • Herbal/Traditional Smoking Cessation Aids
          • Herbal/Traditional Paediatric Dietary Supplements
          • Herbal/Traditional Dietary Supplements
          • Herbal/Traditional Tonics and Bottled Nutritive Drinks
        • Allergy Care
          • Allergy Eye Care
          • Antihistamines/Allergy Remedies (Systemic)
          • Paediatric Allergy Remedies
          • Topical Allergy Remedies/Antihistamines
        • Paediatric Consumer Health
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
          • Paediatric Cough, Cold and Allergy Remedies
            • Paediatric Allergy Remedies
            • Paediatric Cough/Cold Remedies
          • Paediatric Digestive Remedies
            • Paediatric Diarrhoeal Remedies
            • Paediatric Indigestion and Heartburn Remedies
            • Paediatric Laxatives
            • Paediatric Motion Sickness Remedies
          • Paediatric Medicated Skin Care
          • Nappy (Diaper) Rash Treatments
          • Paediatric Vitamins and Dietary Supplements

      Statistics Included

      Statistics Included

      For each category and subcategory you will receive the following data in Excel format:

      From Passport

      • Market sizes
      • Company shares
      • Brand shares
      • Distribution
      • Analysis by format
      • Analysis by positioning
      • Analysis by type
      • Herbal/traditional vs standard
      • Pricing
      • Smoking population - number of adult smokers
      • Smoking prevalence - % of adult population

      Market size details:

      • Retail volume
      • Retail volume % growth
      • Retail volume per capita
      • Retail value retail selling price % growth
      • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price % growth
      • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

      Methodology

      Methodology

      Global insight and local knowledge

      With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

      This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

      Industry specialists

      Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

      Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

      The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

      Country and regional analysts

      Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

      In-country research network

      To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

      Research Methodology

      Our research methods

      Each Euromonitor International industry report is based on a core set of research techniques:

      Desk research

      With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

      • National statistics offices governmental and official sources
      • National and international trade press
      • National and international trade associations
      • Industry study groups and other semi-official sources
      • Company financials and annual reports
      • Broker reports
      • Online databases
      • The financial, business and mainstream press

      Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

      Store checks

      Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

      • Place: We track products in all relevant channels, selective and mass, store and non-store
      • Product: What are innovations in products, pack sizes and formats?
      • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
      • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

      Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

      Trade survey

      Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

      Trade surveys allow us to:

      • Fill gaps in available published data per company
      • Generate a consensus view of the size, structure and strategic direction of the category
      • Access year-in-progress data where published sources are out of date
      • Evaluate the experts’ views on current trends and market developments

      In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

      Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

      Company analysis

      At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

      At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

      Forecasts

      Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

      Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

      Data validation

      All data is subjected to an exhaustive review process, at country, regional and global levels.

      The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

      Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

      Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

      Market analysis

      Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

      Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

      my pages

      Want to find out more about this report?

      If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!